FRANCISCO-JAVIER ROLDAN

Dr. FRANCISCO-JAVIER ROLDAN

Outpatien Department, Instituto Nacional de Cardiología, Mexico City, Ciudad de México, Mexico
+1
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2005 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
JVJesús Vargas-Barrón
Jesús Vargas-Barrón
ARAngel Romero-Cárdenas
Angel Romero-Cárdenas
FRANCISCO-JAVIER ROLDANFRANCISCO-JAVIER ROLDAN
FRANCISCO-JAVIER ROLDAN
MMMarjorie Molina-Carrión
Marjorie Molina-Carrión
CACarmen Avila-Casado
Carmen Avila-Casado
MZMiguel Zabalgoitia
Miguel Zabalgoitia

20 November 2012 in Echocardiography
Verified
Journal Article
Closed access
JVJesús Vargas‐Barrón
Jesús Vargas‐Barrón
FRANCISCO-JAVIER ROLDANFRANCISCO-JAVIER ROLDAN
FRANCISCO-JAVIER ROLDAN
ÁRÁngel Romero‐Cárdenas
Ángel Romero‐Cárdenas
CVClara‐Andrea Vázquez‐Antona
Clara‐Andrea Vázquez‐Antona

20 March 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
Isabel Amador MartínezIsabel Amador Martínez
Isabel Amador Martínez
OAOmar Emiliano Aparicio-Trejo
Omar Emiliano Aparicio-Trejo
Ana Karina Aranda-RiveraAna Karina Aranda-Rivera
Ana Karina Aranda-Rivera
BBBismarck Bernabe-Yepes
Bismarck Bernabe-Yepes
OMOmar Noel Medina-Campos
Omar Noel Medina-Campos
José Pedraza-ChaverriJosé Pedraza-Chaverri
José Pedraza-Chaverri
Type 4 cardiorenal syndrome (CRS-4) is a pathology in which chronic kidney disease (CKD) triggers the development of cardiovascular disease. CKD pathophysiology produces alterations that can affect the bioenergetics of heart mitochondria, causing oxidative stress and reducing antioxidant glutathione (GSH) levels. GSH depletion alters protein function by affecting post-translational modifications such as S-glutathionylation (RS-SG), exacerbating oxidative stress, and mitochondrial dysfunction. On the other hand, N-acetylcysteine (NAC) is an antioxidant GSH precursor that modulates oxidative stress and RS-SG. Moreover, recent studies have found that NAC can activate the Sirtuin 3 (SIRT3) deacetylase in diseases. However, the role of NAC and its effects on mitochondrial function, redox signaling, and SIRT3 modifications in the heart during CRS-4 have not been studied. This study aimed to investigate the role of NAC in mitochondrial function, redox signaling, and SIRT3 in the hearts of animals with CRS-4 at two months of follow-up. Our results showed that the oral administration of NAC (600 mg/kg/day) improved blood pressure and reduced cardiac fibrosis. NACs’ protective effect was associated with preserving cardiac mitochondrial bioenergetics and decreasing these organelles’ hydrogen peroxide (H2O2) production. Additionally, NAC increased GSH levels in heart mitochondria and regulated the redox state, which coincided with an increase in nicotinamide adenine dinucleotide oxidized (NAD+) levels and a decrease in mitochondrial acetylated lysines. Finally, NAC increased SIRT3 levels and the activity of superoxide dismutase 2 (SOD-2) in the heart. Thus, treatment with NAC decreases mitochondrial alterations, restores redox signaling, and decreases SIRT3 disturbances during CRS-4 through an antioxidant defense mechanism.

9 April 2020 in Animals
Verified
Journal Article
Open access
PDF file
OROlivia Rodríguez-Morales
Olivia Rodríguez-Morales
FRANCISCO-JAVIER ROLDANFRANCISCO-JAVIER ROLDAN
FRANCISCO-JAVIER ROLDAN
JVJesús Vargas-Barrón
Jesús Vargas-Barrón
EPEnrique Parra-Benítez
Enrique Parra-Benítez
MMMaría de Lourdes Medina-García
María de Lourdes Medina-García
MAMinerva Arce-Fonseca
Minerva Arce-Fonseca
Chagas disease (ChD) is considered an emerging disease in the USA and Europe. Trypanosoma cruzi genes encoding a trans-sialidase protein and an amastigote-specific glycoprotein were tested as vaccines in canine model. The aim for this study was determining the prophylactic effect of these genes in experimentally infected dogs by echocardiography evaluation to compare with our findings obtained by other techniques published previously. Low fractional-shortening values of non-vaccinated dogs suggested an impairment in general cardiac function. Low left ventricular ejection fraction values found in infected dogs suggested myocardial injury regardless of whether they were vaccinated. Low left ventricular diastolic/systolic diameters suggested that progressive heart damage or heart dilation could be prevented by DNA vaccination. Systolic peak time was higher in non-vaccinated groups, increasing vulnerability to malignant arrhythmias and sudden death. High left ventricular volume suggested a decrease in wall thickness that might lead to increased size of the heart cavity, except in the pBCSP plasmid-vaccinated dogs. There was an echocardiographic evidence of left ventricular dilation and reduction in systolic function in experimental chagasic dogs. Echocardiography allowed a more complete follow-up of the pathological process in the living patient than with other techniques like electrocardiography, anatomopathology, and histopathology, being the method of choice for characterizing the clinical stages of ChD.

12 January 2019 in Molecules
Verified
Journal Article
Open access
PDF file
LILuz Ibarra-Lara
Luz Ibarra-Lara
MAMaria Sánchez Aguilar
Maria Sánchez Aguilar
Elizabeth Soria-CastroElizabeth Soria-Castro
Elizabeth Soria-Castro
JVJesús Vargas-Barrón
Jesús Vargas-Barrón
FRANCISCO-JAVIER ROLDANFRANCISCO-JAVIER ROLDAN
FRANCISCO-JAVIER ROLDAN
ASAlicia Sánchez-Mendoza
Alicia Sánchez-Mendoza
Myocardial infarction (MI) initiates an inflammatory response that promotes both beneficial and deleterious effects. The early response helps the myocardium to remove damaged tissue; however, a prolonged later response brings cardiac remodeling characterized by functional, metabolic, and structural pathological changes. Current pharmacological treatments have failed to reverse ischemic-induced cardiac damage. Therefore, our aim was to study if clofibrate treatment was capable of decreasing inflammation and apoptosis, and reverse ventricular remodeling and MI-induced functional damage. Male Wistar rats were assigned to (1) Sham coronary artery ligation (Sham) or (2) Coronary artery ligation (MI). Seven days post-MI, animals were further divided to receive vehicle (V) or clofibrate (100 mg/kg, C) for 7 days. The expression of IL-6, TNF-α, and inflammatory related molecules ICAM-1, VCAM-1, MMP-2 and -9, nuclear NF-kB, and iNOS, were elevated in MI-V. These inflammatory biomarkers decreased in MI-C. Also, apoptotic proteins (Bax and pBad) were elevated in MI-V, while clofibrate augmented anti-apoptotic proteins (Bcl-2 and 14-3-3ε). Clofibrate also protected MI-induced changes in ultra-structure. The ex vivo evaluation of myocardial functioning showed that left ventricular pressure and mechanical work decreased in infarcted rats; clofibrate treatment raised those parameters to control values. Echocardiogram showed that clofibrate partially reduced LV dilation. In conclusion, clofibrate decreases cardiac remodeling, decreases inflammatory molecules, and partly preserves myocardial diameters.

10 August 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
CCCuevas-Lopez Cuevas-Lopez
Cuevas-Lopez Cuevas-Lopez
EREdgar Romero Ramírez
Edgar Romero Ramírez
FAFernando Garcia Arroyo
Fernando Garcia Arroyo
ETEdilia Tapia
Edilia Tapia
JUAN CARLOS LEON CONTRERASJUAN CARLOS LEON CONTRERAS
JUAN CARLOS LEON CONTRERAS
OAOmar Emiliano Aparicio-Trejo
Omar Emiliano Aparicio-Trejo
The incidence of kidney disease is increasing worldwide. Acute kidney injury (AKI) can strongly favor cardio-renal syndrome (CRS) type 3 development. However, the mechanism involved in CRS development is not entirely understood. In this sense, mitochondrial impairment in both organs has become a central axis in CRS physiopathology. This study aimed to elucidate the molecular mechanisms associated with cardiac mitochondrial impairment and its role in CRS development in the folic acid-induced AKI (FA-AKI) model. Our results showed that 48 h after FA-AKI, the administration of N-acetyl-cysteine (NAC), a mitochondrial glutathione regulator, prevented the early increase in inflammatory and cell death markers and oxidative stress in the heart. This was associated with the ability of NAC to protect heart mitochondrial bioenergetics, principally oxidative phosphorylation (OXPHOS) and membrane potential, through complex I activity and the preservation of glutathione balance, thus preventing mitochondrial dynamics shifting to fission and the decreases in mitochondrial biogenesis and mass. Our data show, for the first time, that mitochondrial bioenergetics impairment plays a critical role in the mechanism that leads to heart damage. Furthermore, NAC heart mitochondrial preservation during an AKI event can be a valuable strategy to prevent CRS type 3 development.